Category Archives: Pr Newswire

Range Impact Reports 2Q 2024 Financial Results

CLEVELAND, OHIO, Aug. 14, 2024 (GLOBE NEWSWIRE) — Range Impact, Inc. (OTC: RNGE) (“Range Impact”), a public impact investing company dedicated to acquiring, reclaiming and repurposing mine sites in Appalachia, reported its results for the second quarter ended June 30, 2024. Range Impact’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 […]

Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results

Presented updated data on 13 participants from ongoing Phase 1b trial evaluating tegoprubart for prevention of rejection in kidney transplantation 80 participants (two-thirds of projected recruitment) enrolled in Phase 2 BESTOW trial Completed an oversubscribed $50 million private placement; Company expects sufficient liquidity through December 2025 IRVINE, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) — Eledon […]

SciSparc Updates Regarding the Status of the AutoMax Merger

SciSparc provides investors with an update regarding the status of the merger agreement with AutoMax, including the court’s approval of AutoMax’s petition to convene special class meetings of its shareholders to approve the Merger with the Company TEL AVIV, Israel, Aug. 14, 2024 (GLOBE NEWSWIRE) —  SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty […]

Ivonescimab (PD-1/VEGF) Received Priority Review from China’s NMPA for First-Line Treatment of PD-L1 Positive NSCLC

The Second Indication of Ivonescimab in NSCLC2L+ EGFRm NSCLC Already Approved in May 2024 HONG KONG, Aug. 15, 2024 /PRNewswire/ — Akeso, Inc. (HKEX: 9926.HK) (“Akeso,”) today announced that the National Center for Drug Evaluation of the State Drug Administration of the People’s Republic of China (NMPA CDE) has granted priority review of the supplemental […]

Moatable Reports Second Quarter 2024 Financial Results

PHOENIX, Aug. 15, 2024 /PRNewswire/ — Moatable, Inc. (OTC: MTBLY) (“Moatable” or the “Company”), a leading US-based SaaS company, today reported its second quarter 2024 financial results. Second Quarter 2024 Financial Highlights Revenue increased 19% over Q2 2023 to $15.3 million in Q2 2024; Revenue for the six months ended June 30, 2024 increased 17%, […]

MDJM LTD Appoints Professor Duncan Murray Campbell to Promote Cultural Initiatives in the UK

LETHAM, Scotland, Aug. 15, 2024 /PRNewswire/ — MDJM LTD (Nasdaq: MDJH) (the “Company” or “MDJM”), an integrated global culture-driven asset management company, announced today the appointment of Professor Duncan Murray Campbell to the Expert Committee of its wholly owned subsidiary, MD Local Global Limited, a United Kingdom Company. Professor Campbell’s extensive expertise in Chinese cultural […]

MEGA MATRIX CORP. Announces Second Quarter 2024 Financial Results

PALO ALTO, Calif., Aug. 15, 2024 /PRNewswire/ — Mega Matrix Corp. (“MPU” or the “Company”) (NYSE American: MPU), today announced financial results for its second quarter ended June 30, 2024.  Operating Highlights User recharge totaled $15.8 million in the first half of 2024, with 62.0% generated from the U.S. In the first half of 2024, […]

CHIVAS REGAL SCORES BIG WITH MULTI-YEAR GLOBAL ARSENAL PARTNERSHIP

The iconic blended Scotch whisky will become the club’s Official Whisky Partner celebrating their shared ambition for collective success ahead of the new season To celebrate the partnership, Chivas Regal and Arsenal buy a pre-match round for the local community and spirited Gooners with a Chivas Highball giveaway across local pubs LONDON, Aug. 15, 2024 /PRNewswire/ […]

Invivyd Reports Second Quarter 2024 Financial Results and Recent Business Highlights

PEMGARDA™ launched commercially in Q2 2024 with $2.3 million of net product revenue Notable acceleration of commercial results in early Q3 2024, with the anticipated peak fall/winter respiratory virus season approaching New commercial leadership with Chief Commercial Officer, Tim Lee, an experienced biopharmaceutical leader with demonstrated commercial success Achieved Medicare and Medicaid coverage, rapid growth […]

Kent Kresa to Retire from MannKind’s Board of Directors; Steven B. Binder to be Appointed to the Board

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, announced today that Kent Kresa has decided to retire from MannKind’s Board of Directors effective September […]